Trial
NCT02234687
A mGlu2/3 Agonist in the Treatment of PTSD
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
—
Condition
Post-traumatic Stress Disorder
Intervention
Pomaglumetad Methionil 160mg
Why stopped
The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-02